Precision T Cells Targeting Multiple Tumor-Associated Antigens
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Precision T Cells Targeting Multiple Tumor-Associated Antigens, covering 2016-01-01 to 2016-01-01. Get the full timeline:
Most recent: Clinical Trial Update: Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma [Phase 1, Phase 2]